Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2024

  • No. of Pages: 480
  • Publish Date: April-2018
  • Category: Pharmaceutical and Healthcare
Electronic Access - Single User License
CD-ROM Mail Delivery
Hard Copy Mail Delivery
Electronic Access - Multi-User License

Buy USD 20,000 Worth Of Reports (Single User/Multi User License) In USD 8000 Only

For Latest Publication Visit Following Report Weblink


"Click Here: "Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028"



“Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2024” Report Highlights:


  • Nanoparticle Drug  Market: US$ 200 Billion Opportunity By 2024

  • Global Pipeline For Nanoparticle Drug: 231 Drugs

  • Drugs In and Above Phase II Trials: 33 Drugs

  • Marketed Nanoparticle Drugs: 13 Drugs

  • Dosage, Price and Patent Analysis Of Key Drugs

  • Upcoming Nanoparticle Drug Delivery Techniques

  • Global Nanoparticle Drug Clinical Pipeline by Company, Indication and Phase


Drug delivery plays a significant role in determining the therapeutic outcome of a treatment. The limitations of conventional drug delivery system such as low bioavailability of therapeutics, poor patient compliance and fluctuation in concentration has led to a dire need for the development of new, better and safer delivery method with enhanced therapeutic outcome and safety.


The practice of drug delivery has changed dramatically in the past few decades with substantial changes being anticipated in the future. An emerging method that clearly stands out is the use of nanotechnology in drug delivery which utilizes specially designed nanoparticles to enhance drug delivery more effectively and precisely with additional advantages such as longer circulation delivery, longer half-lives, better bioavailability, improved pharmacokinetics and reduced side effects.


Additionally, nanoparticles also have the ability to transport drug molecules across the blood brain barrier which can be exploited to develop revolutionizing therapeutics for clinical conditions such as Parkinson's disease, Alzheimer's disease, schizophrenia and depression. It has also raised hope in complex disease like brain tumor – which is currently impossible to treat with conventional drug delivery methods.


An insight into the market trends shows that the ability of nanoparticles to enhance therapeutic outcome by a significant margin has led pharmaceutical companies to develop nanoparticle formulation of popular drugs like Megace ES(Enhanced Stability), Estrasorb (estradiol topical emulsion)and Triglide(Nanocrystal formulation of Tricor). Nanoparticle formulations of popular cancer therapeutics like Doxorubicin and Taxol has also been well received in the cancer therapeutic segment due to longer half-lives and reduced side effects.


Advancement in nanotechnology has resulted in the entry of many types of nanoparticles in the market. Nanocrystal and liposomes are currently the most popular nanoparticles in use, followed by micelles and dendrimers. Nanocrystal, liposomal and micelle formulations of therapeutics are being developed and marketed which is bound to increase the market size in the future.


Geographical Analysis of the Nanoparticle drug delivery method projects the increasing dominance of US with more than 40% of the global market, followed by Europe. However, the market size is anticipated to increase in the Asia Pacific and Latin American region during the forecast period due to multiple growth factors supporting the analysis, such as increase in patient base and the rising interest of key players like Johnson and Johnson and Novartis in the region.


KuicK Research Estimates the Global nanoparticle drug market to reach over US$ 200 Billion by 2024 at a CAGR of 10%. Growth promoting factors like increase in global prevalence of various clinical indications like cancer, diabetes and rheumatoid arthritis are bound to fuel the market growth with oncology being the dominant segment. The increasing demand for effective treatment methods to provide for the rising pool of patients are expected to help the segment retain dominance over the report’s forecast period as well.


The nanoparticles drug delivery market however faces some major challenges that are anticipated to hamper with its future growth. High demand of investments, scientific and technical limitations and overcrowding of vendors and marketing challenges such as exorbitant pricing of therapeutics, limited market penetration and low awareness are hurdles that need to be taken care of to enhance the potential of nanoparticle drug delivery segment.


KuicK Research report on global nanoparticle drug delivery market provides an in-depth analysis of the market with special emphasis on the Global market size, current market trends, dynamics and other factors that might have an impact on the market. Comparative price, dosage and therapy cost analysis of Original drugs with Nanoparticle formulations analyses the promising potential of Nanoparticle drug delivery, ultimately proving its superiority. KuicK Research analysis is based on extensive research from both primary and secondary sources, highlighting the market opportunities regionally and ensuring an optimistic future forecast of the global nanoparticles drug delivery market.

Need custom market research solution? We can help you with that too.